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HuR (ELAV11 (embryonic lethal, abnormal vision)-like 1), a ubiquitously expressed member of the ELAV-like RNA-binding 
protein family, has been shown to regulate the stability and translation of mRNAs that encode factors regulating cellular se-
nescence, thereby impacting on aging. In this review, we discuss the current knowledge of HuR’s role in vascular cell senes-
cence and vascular aging. 
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Vascular cell senescence is defined as a state of indefinite 
growth cessation that accompanies the replicative exhaus-
tion of cells or growth arrest triggered by cellular damage or 
oncogenic signaling [1]. It is accepted that vascular cell 
senescence contributes to vascular aging, a process of ex-
hausted vascular function accompanied by changes includ-
ing luminal dilation, increase in arterial stiffness, endotheli-
al dysfunction, and diffuse intimal thickening [2]. The ex-
pression of senescence-associated genes that govern the 
progression of aging is regulated at multiple levels. In addi-
tion to transcriptional mechanisms, studies over the past 
decade have revealed that post-transcriptional gene regula-
tion, especially through changes in mRNA turnover and 
translation, critically influences protein expression patterns 
in the senescent cell [1].  
Although the mechanisms controlling mRNA turnover or 
translation are not fully understood, interactions between 
regulatory factors and mRNAs are thought to be important 
for post-transcriptional regulation. The regulatory factors 
involved in mRNA turnover and translation include regula-
tory RNA binding proteins, microRNAs and long non-  
coding RNAs (lncRNAs) [1,3,4]. HuR, a ubiquitously ex-
pressed member of the Hu RNA-binding protein family, has 
been widely shown to stabilize various mRNAs. HuR also 
acts as an important regulator of translation and nuclear 
export of target mRNAs [1]. The molecular distinction be-
tween the function of HuR as a stabilizing factor for some 
target mRNAs and a factor that modulates translation of 
other target mRNAs is not understood in detail. It is well 
established that HuR binds to mRNAs bearing U-rich or 
AU-rich sequences (AREs), which are typically present in 
their 3′-untranslated regions (3′-UTRs) [5]. This review 
focuses on the RNA-binding protein HuR, which is in-
volved in the regulation of turnover or translation of 
mRNAs encoding vascular aging-related proteins.    
1  Post-transcriptional regulation in vascular 
cell senescence 
The expression of senescence-associated genes is of critical 
importance for governing the progression towards and the 
maintenance of vascular senescence. Examples of genes 
whose expression is elevated during vascular aging or in 
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senescent vascular cells include p16INK4, p21CIP1, p27KIP1, 
ICAM-1, TGF-β2, GADD153, PAI-1, IGFBP-5 and fibron-
ectin, while genes whose expression is reduced include 
SIRT1, eNOS, cyclin A, cyclin B1, cdc2, Id-1, and DHP1 
[6–8]. The regulation of aging-related genes at the tran-
scriptional level has been intensively studied for several 
decades. Additionally, studies over the past decade have 
revealed that post-transcriptional regulation, especially 
through control of mRNA turnover and translation, critical-
ly influences protein expression patterns in the senescent 
cell [1,9]. Among the post-transcriptional regulatory factors, 
the RNA-binding protein HuR is particularly influential in 
the establishment of senescence-associated protein profiles. 
2  HuR and post-transcriptional regulation in 
vascular cell senescence  
Proliferation arrest is a common and typical characteristic of 
cell senescence [10]. Therefore, genes involved in the regu-
lation of cell division are regulators of cell senescence. In-
terestingly, HuR was described as a regulator of the cell 
cycle, at least in part, by mediating cell cycle-dependent 
stabilization of mRNAs encoding cyclins A and B1 (Table 1) 
[11]. During cell senescence, the loss of HuR function re-
duces the stability of mRNAs encoding cyclin A, cyclin B1, 
and c-fos, which in turn causes a reduction in the expression 
of these cell cycle regulators and enhanced cellular senes-
cence [12]. In different cell types, elevation of the CDK 
inhibitor p16 contributes to proliferation arrest and the se-
nescence phenotype. HuR was found to bind to the p16INK4 
3′-UTR and to recruit AUF1 and Ago2 (an important com-
ponent of the RNA-induced silencing complex (RISC)). 
This led to the destabilization of the p16 mRNA in replica-
tive senescence (Table 1) [13]. The secondary structure of 
the p16 3′-UTR is important for the function of HuR, be-
cause disruption of the secondary structure by point muta-
tion completely abolished the effect of HuR in destabilizing 
p16 mRNA [13]. In a recent study, the tRNA methyltrans-
ferase NSun2 was shown to methylate the p16 3′-UTR at 
A988 (m6A). Methylation by NSun2 antagonizes the inter-
action of HuR with the p16 3′-UTR, thereby stabilizing the 
p16 3′-UTR. In oxidative stress-induced cell senescence, the 
NSun2-p16 regulatory process is responsible for elevating 
p16 levels [14]. p27Kip1 is another important gene for the 
growth and senescence of vascular endothelial and vascular 
smooth muscle cells [15,16]. HuR was also described as a 
repressor of p27 of translation (Table 1). The repression of 
p27 translation by HuR may depend on the association of 
HuR with the internal ribosomal entry site (IRES) located in 
the p27 5′-UTR [17]. The impact of HuR upon the above 
regulatory factors of the cell division cycle has not been 
reported with respect to vascular aging; however, this regu-
lation may be important for this process because reduced 
levels of HuR during vascular aging are accompanied by 
decreased levels of cyclin A and cyclin B1 as well as in-
creased levels of p16 and p27 [6,7,18].  
Apart from the aforementioned target mRNAs, HuR has 
also been reported to regulate the expression of SIRT1, 
TNF-α, IL-6, IL-8, eNOS, ICAM1, VCAM-1, and VEGF 
(Table 1) [923]. HuR can stabilize the mRNAs of SIRT1, 
TNF-α, IL-6, IL-8, and VEGF by recognizing the AREs 
located in the 3′-UTRs of these mRNAs [19,20,22,23]. Re-
duced levels of SIRT1 were observed in senescent human 
diploid fibroblasts, and SIRT1 has a well-established impact 
upon senescence, certain diseases and life-span [24,25]. 
Reduction of VEGF levels has also been described as an 
important event in vascular aging, and VEGF can prevent 
human vascular endothelial cells from senescence [8]. Be-
cause HuR, SIRT1 and VEGF levels decline with vascular 
aging [6,8,24], it is possible that the reduced SIRT1 and 
VEGF levels in senescent cells may result from the loss of  
Table 1  Role of HuR in the regulation of vascular aging-related genes 
Target genes 
mRNA stability Translation efficiency 
Increase Decrease Increase Decrease 
cyclin A Increase
 
[10,11]    
cyclin B1 Increase [10,11]    
p16  Decrease [12]   
p27    Decrease [14,15] 
TNF-alpha Increase [18]    
VEGF Increase [19]    
eNOS ND ND ND ND [20] 
SIRT1 Increase [21]    
IL-8 Increase [25]    
IL-6 Increase [25]    
ICAM-1 Increase [27]    
VCAM-1 Increase [27]    
COX2 Increase [29]    
a) The vascular aging-related genes whose expressing is regulated by HuR are listed. The regulation level (mRNA stability or translation), effect (in-
crease or decrease), and the references are presented. ND, not determined. 
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HuR-mediated mRNA stabilization. Endothelial nitric oxide 
synthase (eNOS), ICAM-1 and VCAM-1 are also targets of 
HuR. Indeed, a study by Rhee et al. [21] indicated that HuR 
may regulate eNOS, ICAM-1, and VCAM-1 by activating 
NF-κB. There is no supporting evidence for the direct asso-
ciation of HuR to eNOS mRNA; however, HuR is unable to 
influence the translocation of NF-κB directly; therefore, 
HuR may directly bind to eNOS mRNA and regulate its 
turnover or translation. This, however, requires confirma-
tion. In summary, by regulating vascular senescence-   
associated genes (Table 1), HuR may act as a regulator of 
vascular cell senescence.  
3  HuR and in vivo vascular aging  
By secreting numerous cytokines, growth factors, and pro-
teases (the senescence-associated secretary phenotype 
(SASP)), senescent cells contribute to tissue repair, tumor 
promotion, and in vivo aging [26]. Given that HuR regulates 
genes controlling vascular cell aging, studies have been 
conducted to investigate whether HuR influences the pro-
cess of in vivo vascular aging. In aged rats, the expression 
of HuR in the aorta was significantly decreased at the 
mRNA and protein levels [8]. Treatment of apolipopro-
tein-E-deficient mice with TNF-α induced HuR transloca-
tion and interaction between HuR and the 3′-UTR of 
ICAM-1 mRNA, thereby increasing ICAM-1 expression 
and enhancing leukocyte adhesion [27]. Phosphorylation of 
HuR by PKC enhances HuR binding to target mRNAs 
[28,29]. In the retina of streptozotocin (STZ)-induced dia-
betic rats, PKCβ/HuR activation was accompanied by en-
hanced VEGF protein expression that was blunted by a 
PKCβ inhibitor [30]. Therefore, HuR may be an important 
player in the process of in vivo vascular aging.   
4  Conclusion 
The altered abundance of genes expressed during vascular 
cell senescence determines the progression of cell aging. 
Undoubtedly, future studies will identify additional genes 
involved in senescence and HuR may target more mRNAs 
than we are currently aware of. Although the mechanisms 
underlying HuR-mediated regulatory events remain largely 
unknown, it is accepted that HuR often influences the fate 
of target mRNAs by working in association with other 
RNA-binding proteins and post-transcriptional factors (e.g., 
microRNAs) [13,31,32]. The association of HuR with other 
post-transcriptional factors and the influence of these asso-
ciations on the regulation of genes involved in vascular ag-
ing should be carefully studied. In addition, regulation of 
HuR translation by miR-519, miR-146, miR-16, miR-125a 
and HuR itself have been reported [33–38]. The 
miR-519-HuR and HuR-HuR regulatory processes impact 
on the expression of HuR in the replicative senescence of 
human diploid fibroblast [33,35]. The impact of the above 
regulatory processes in vascular aging or age-related decline 
therefore needs to be further investigated.  
This work was supported by the National Natural Science Foundation of 
China (81230008, 91339114) and 111 project of Ministry of Education of 
China (B07001).   
1 Wang W. Regulatory RNA-binding proteins in senescence. Ageing 
Resh Rev, 2012, 11: 485–490 
2 Laurent S. Defining vascular aging and cardiovascular risk. J 
Hypertens, 2012, 30: S3–8 
3 Inukai S, Slack F. microRNAs and the genetic network in aging. J 
Mol Biol, 2013, 425: 3601–3608 
4 Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene reg-
ulation by long noncoding RNA. J Mol Biol, 2013, 425: 3723–3730 
5 Peng SS, Chen CY, Xu N, Shyu AB. RNA stabilization by the 
AU-rich element binding protein, HuR, an ELAV protein. EMBO J, 
1998, 17: 3461–3470 
6 Minamino T, Miyauchi H, Yoshida T, Tateno K, Kunieda T, Komuro 
I. Vascular cell senescence and vascular aging. J Mol Cell Cardiol, 
2004, 36: 175–183 
7 Foreman KE, Tang J. Molecular mechanisms of replicative senes-
cence in endothelial cells. Exp Gerontol, 2003, 38: 1251–1257 
8 Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF. Vascular 
permeability factor/vascular endothelial growth factor (VPF/VEGF) 
delays and induces escape from senescence in human dermal micro-
vascular endothelial cells. Oncogene, 1997, 14: 2025–2032 
9 Brewer G. Messenger RNA decay during aging and development. 
Ageing Res Rev, 2002, 1: 607–625 
10 Hayflick L, Moorhead PS. The serial cultivation of human diploid 
cell strains. Exp Cell Res, 1961, 25: 585–621 
11 Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M. HuR regu-
lates cyclin A and cyclin B1 mRNA stability during cell proliferation. 
EMBO J, 2000, 19: 2340–2350 
12 Wang W, Yang X, Cristofalo V, Holbrook N, and Gorospe M. Loss 
of HuR is linked to reduced expression of proliferative genes during 
replicative senescence. Mol Cell Biol, 2001, 21: 5889–5898 
13 Chang N, Yi J, Guo G, Liu X, Shang Y, Tong T, Cui Q, Zhan M, 
Gorospe M, Wang W. HuR uses AUF1 as a cofactor to promote 
p16INK4 mRNA decay. Mol Cell Biol, 2010, 30: 3875–3886 
14 Zhang X, Liu Z, Yi J, Tang H, Xing J, Yu M, Tong T, Shang Y, 
Gorospe M, Wang W. NSun2 stabilizes p16INK4 mRNA by methyl-
ating the p16 3′UTR. Nat Commun, 2012, 3: 712 
15 Werth D, Grassi G, Konjer N, Dapas B, Farra R, Giansante C, Kan-
dolf R, Guarnieri G, Nordheim A, Heidenreich O. Proliferation of 
human primary vascular smooth muscle cells depends on serum re-
sponse factor. Eur J Cell Biol, 2010, 89: 216–224 
16 Li M, Chiu JF, Gagne J, Fukagawa NK. Age-related differences in 
insulin-like growth factor-1 receptor signaling regulates Akt/ 
FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. J 
Cell Physiol, 2008, 217: 377–387 
17 Kullmann M, Göpfert U, Siewe B, Hengst L. ELAV/Hu proteins in-
hibit p27 translation via an IRES element in the p27 5′UTR. Genes 
Dev, 2012, 16: 3087–3099 
18 Klöss S, Rodenbach D, Bordel R, Mülsch A. Human-antigen R (HuR) 
expression in hypertension: downregulation of the mRNA stabilizing 
protein HuR in genetic hypertension. Hypertension, 2005, 45: 
1200–1206 
19 Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. The 
3′ untranslated region of tumor necrosis factor alpha mRNA is a tar-
get of the mRNA-stabilizing factor HuR. Mol Cell Biol, 2001, 21: 
721–730 
20 Levy NS, Chung S, Furneaux H, Levy AP. Hypoxic stabilization of 
866 Wang WG   Sci China Life Sci   August (2014) Vol.57 No.8 
vascular endothelial growth factor mRNA by the RNA-binding pro-
tein HuR. J Biol Chem, 1998, 273: 6417–6423 
21 Rhee WJ, Ni CW, Zheng Z, Chang K, Jo H, Bao G. HuR regulates 
the expression of stress-sensitive genes and mediates inflammatory 
response in human umbilical vein endothelial cells. Proc Natl Acad 
Sci USA, 2010, 107: 6858–6863 
22 Abdelmohsen K, Pullmann R Jr., Lal A, Kim HH, Galban S, Yang X, 
Blethrow JD, Walker M, Shubert J, Gillespie DA, Furneaux H, 
Gorospe M. Phosphorylation of HuR by Chk2 regulates SIRT1 ex-
pression. Mol Cell, 2007, 25: 543–557 
23 Nabors LB, Gillespie GY, Harkins L, King PH. HuR, a RNA stability 
factor, is expressed in malignant brain tumors and binds to adenine- 
and uridine-rich elements within the 3′ untranslated regions of cyto-
kine and angiogenic factor mRNAs. Cancer Res, 2001, 61: 
2154–2161 
24 Chen HZ, Wan YZ, Liu DP. Cross-talk between SIRT1 and p66Shc 
in vascular diseases. Trends Cardiovasc Med, 2013, 23: 237–241 
25 Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, 
Howitz KT, Gorospe M, de Cabo R, Sinclair DA. Calorie restriction 
promotes mammalian cell survival by inducing the SIRT1 deacety-
lase. Science, 2004, 305: 390–392 
26 Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol, 
2011, 192: 547–556 
27 Wu WH, Wang SH, Kuan II, Kao YS, Wu PJ, Liang CJ, Chien HF, 
Kao CH, Huang CJ, Chen YL. Sesamin attenuates intercellular cell 
adhesion molecule-1 expression in vitro in TNF-alpha-treated human 
aortic endothelial cells and in vivo in apolipoprotein-E-deficient mice. 
Mol Nutr Food Res, 2010, 54: 1340–1350 
28 Doller A, Pfeilschifter J, Eberhardt W. Signalling pathways regulat-
ing nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. 
Cell Signal, 2008, 20: 2165–2173 
29 Doller A, Schlepckow K, Schwalbe H, Pfeilschifter J, Eberhardt W. 
Tandem phosphorylation of serines 221 and 318 by protein kinase 
Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling 
of HuR. Mol Cell Biol, 2010, 30: 1397–1410 
30 Amadio M, Bucolo C, Leggio GM, Drago F, Govoni S, Pascale A. 
The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem 
Pharmacol, 2010, 80: 1230–1237 
31 Kim MY, Hur J, Jeong S. Emerging roles of RNA and RNA-binding 
protein network in cancer cells. BMB Rep, 2009, 42: 125–130 
32 Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, 
Gorospe M. Concurrent versus individual binding of HuR and AUF1 
to common labile target mRNAs. EMBO J, 2004, 23: 3092–3102 
33 Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe 
M, Abdelmohsen K. microRNA profiling in human diploid fibro-
blasts uncovers miR-519 role in replicative senescence. Aging (Al-
bany NY), 2010, 2: 333–343 
34 Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M. miR-519 re-
duces cell proliferation by lowering RNA-binding protein HuR levels. 
Proc Natl Acad Sci USA, 2008, 105: 20297–20302 
35 Yi J, Chang N, Liu X, Guo G, Xue L, Tong T, Gorospe M, Wang W. 
Reduced nuclear export of HuR mRNA by HuR is linked to the loss 
of HuR in replicative senescence. Nucleic Acids Res, 2010, 38: 
1547–1558 
36 Cheng HS, Sivachandran N, Lau A, Boudreau E, Zhao JL, Baltimore 
D, Delgado-Olguin P, Cybulsky MI, Fish JE. microRNA-146 re-
presses endothelial activation by inhibiting pro-inflammatory path-
ways. EMBO Mol Med, 2013, 5: 949–966 
37 Xu F, Zhang X, Lei Y, Liu X, Liu Z, Tong T, Wang W. Loss of re-
pression of HuR translation by miR-16 may be responsible for the 
elevation of HuR in human breast carcinoma. J Cell Biochem, 2010, 
111: 727–734 
38 Guo X, Wu Y, Hartley RS. microRNA-125a represses cell growth by 
targeting HuR in breast cancer. RNA Biol, 2009, 6: 575–583 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
